![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
23
PharmaCompass offers a list of Nitrofurantoin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nitrofurantoin manufacturer or Nitrofurantoin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nitrofurantoin manufacturer or Nitrofurantoin supplier.
PharmaCompass also assists you with knowing the Nitrofurantoin API Price utilized in the formulation of products. Nitrofurantoin API Price is not always fixed or binding as the Nitrofurantoin Price is obtained through a variety of data sources. The Nitrofurantoin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NITROFURANTOIN MACROCRYSTALLINE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NITROFURANTOIN MACROCRYSTALLINE, including repackagers and relabelers. The FDA regulates NITROFURANTOIN MACROCRYSTALLINE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NITROFURANTOIN MACROCRYSTALLINE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NITROFURANTOIN MACROCRYSTALLINE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NITROFURANTOIN MACROCRYSTALLINE supplier is an individual or a company that provides NITROFURANTOIN MACROCRYSTALLINE active pharmaceutical ingredient (API) or NITROFURANTOIN MACROCRYSTALLINE finished formulations upon request. The NITROFURANTOIN MACROCRYSTALLINE suppliers may include NITROFURANTOIN MACROCRYSTALLINE API manufacturers, exporters, distributors and traders.
click here to find a list of NITROFURANTOIN MACROCRYSTALLINE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NITROFURANTOIN MACROCRYSTALLINE DMF (Drug Master File) is a document detailing the whole manufacturing process of NITROFURANTOIN MACROCRYSTALLINE active pharmaceutical ingredient (API) in detail. Different forms of NITROFURANTOIN MACROCRYSTALLINE DMFs exist exist since differing nations have different regulations, such as NITROFURANTOIN MACROCRYSTALLINE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NITROFURANTOIN MACROCRYSTALLINE DMF submitted to regulatory agencies in the US is known as a USDMF. NITROFURANTOIN MACROCRYSTALLINE USDMF includes data on NITROFURANTOIN MACROCRYSTALLINE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NITROFURANTOIN MACROCRYSTALLINE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NITROFURANTOIN MACROCRYSTALLINE suppliers with USDMF on PharmaCompass.
A NITROFURANTOIN MACROCRYSTALLINE CEP of the European Pharmacopoeia monograph is often referred to as a NITROFURANTOIN MACROCRYSTALLINE Certificate of Suitability (COS). The purpose of a NITROFURANTOIN MACROCRYSTALLINE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of NITROFURANTOIN MACROCRYSTALLINE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of NITROFURANTOIN MACROCRYSTALLINE to their clients by showing that a NITROFURANTOIN MACROCRYSTALLINE CEP has been issued for it. The manufacturer submits a NITROFURANTOIN MACROCRYSTALLINE CEP (COS) as part of the market authorization procedure, and it takes on the role of a NITROFURANTOIN MACROCRYSTALLINE CEP holder for the record. Additionally, the data presented in the NITROFURANTOIN MACROCRYSTALLINE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the NITROFURANTOIN MACROCRYSTALLINE DMF.
A NITROFURANTOIN MACROCRYSTALLINE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. NITROFURANTOIN MACROCRYSTALLINE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of NITROFURANTOIN MACROCRYSTALLINE suppliers with CEP (COS) on PharmaCompass.
A NITROFURANTOIN MACROCRYSTALLINE written confirmation (NITROFURANTOIN MACROCRYSTALLINE WC) is an official document issued by a regulatory agency to a NITROFURANTOIN MACROCRYSTALLINE manufacturer, verifying that the manufacturing facility of a NITROFURANTOIN MACROCRYSTALLINE active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting NITROFURANTOIN MACROCRYSTALLINE APIs or NITROFURANTOIN MACROCRYSTALLINE finished pharmaceutical products to another nation, regulatory agencies frequently require a NITROFURANTOIN MACROCRYSTALLINE WC (written confirmation) as part of the regulatory process.
click here to find a list of NITROFURANTOIN MACROCRYSTALLINE suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NITROFURANTOIN MACROCRYSTALLINE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NITROFURANTOIN MACROCRYSTALLINE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NITROFURANTOIN MACROCRYSTALLINE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NITROFURANTOIN MACROCRYSTALLINE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NITROFURANTOIN MACROCRYSTALLINE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NITROFURANTOIN MACROCRYSTALLINE suppliers with NDC on PharmaCompass.
NITROFURANTOIN MACROCRYSTALLINE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NITROFURANTOIN MACROCRYSTALLINE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NITROFURANTOIN MACROCRYSTALLINE GMP manufacturer or NITROFURANTOIN MACROCRYSTALLINE GMP API supplier for your needs.
A NITROFURANTOIN MACROCRYSTALLINE CoA (Certificate of Analysis) is a formal document that attests to NITROFURANTOIN MACROCRYSTALLINE's compliance with NITROFURANTOIN MACROCRYSTALLINE specifications and serves as a tool for batch-level quality control.
NITROFURANTOIN MACROCRYSTALLINE CoA mostly includes findings from lab analyses of a specific batch. For each NITROFURANTOIN MACROCRYSTALLINE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NITROFURANTOIN MACROCRYSTALLINE may be tested according to a variety of international standards, such as European Pharmacopoeia (NITROFURANTOIN MACROCRYSTALLINE EP), NITROFURANTOIN MACROCRYSTALLINE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NITROFURANTOIN MACROCRYSTALLINE USP).